Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis

Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis

Item
http://www.wikidata.org/entity/Q35636708
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway.Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report.A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis.Economic considerations of the treatment of ankylosing spondylitis.A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature.The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis.Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials.Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system.Cost–effectiveness of tumor necrosis factor-α antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
P2860

Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis

Item
http://www.wikidata.org/entity/Q35636708
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Markov model into the cost-uti ...... active ankylosing spondylitis
@ast
Markov model into the cost-uti ...... active ankylosing spondylitis
@en
type
label
Markov model into the cost-uti ...... active ankylosing spondylitis
@ast
Markov model into the cost-uti ...... active ankylosing spondylitis
@en
prefLabel
Markov model into the cost-uti ...... active ankylosing spondylitis
@ast
Markov model into the cost-uti ...... active ankylosing spondylitis
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Markov model into the cost-uti ...... active ankylosing spondylitis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932